Overview
At BioInnovate Solutions, we are developing cutting-edge diagnostic tools aimed at revolutionizing early detection of diseases. With a unique approach that combines proprietary technology and data analytics, our products enable faster and more accurate diagnoses, significantly improving patient outcomes. Since our inception in 2024, we have successfully completed initial product trials and received positive feedback from medical professionals and institutions. Our prototype has demonstrated a 30% increase in diagnostic accuracy compared to existing methods. As we enter mid-2026, our goal is to transition from a prototype phase to full-scale production. We are looking for an investor who shares our vision and can provide the necessary capital to facilitate this next step. The funds raised will be pivotal in scaling our operations, enhancing our R&D efforts, and navigating regulatory approvals for market introduction. We believe that with the increasing global demand for efficient diagnostics, BioInnovate Solutions is poised to capture significant market share, particularly as healthcare systems prioritize early intervention and disease prevention. Our unique selling proposition lies…
Use of funds
The $235,000 will be allocated as follows:
- Product Development (40%): Enhancing our diagnostic technology and moving from prototype to final product.
- Clinical Trials (30%): Conducting necessary trials to ensure safety and efficacy for regulatory approval.
- Marketing and Sales (20%): Developing marketing strategies to penetrate medical institutions and secure partnerships.
- Operational Expenses (10%): Covering administrative costs and maintaining operational functionality during growth.
Open case
Open this case to get the detailed business plan and direct contact with the founder or seeker.